THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of “light cannabis”
- 8 April 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 58 (5), 682-689
- https://doi.org/10.1515/cclm-2019-0119
Abstract
Background: “Light cannabis” is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentration lower than 0.2% and variable cannabidiol (CBD) content. We studied THC and CBD excretion profiles in blood, oral fluid (OF) and urine after smoking one or four light cannabis cigarettes. Methods: Blood, OF and urine samples were obtained from six healthy light cannabis consumers after smoking one 1 g cigarette containing 0.16% THC and 5.8% CBD and from six others after smoking four 1 g cigarettes within 4 h. Sample collection began 0.5 and 4.5 h after smoking one or four cigarettes, respectively. Cannabinoid concentrations were quantified by gas chromatography-mass spectrometry (GC-MS). Results: At the first collection, the highest THC and CBD concentrations occurred in blood (THC 7.0–10.8 ng/mL; CBD 30.2–56.1 ng/mL) and OF (THC 5.1–15.5 ng/mL; CBD 14.2–28.1 ng/mL); similar results occurred 0.5 h after the last of four cigarettes in blood (THC 14.1–18.2 ng/mL, and CBD 25.6–45.4 ng/mL) and OF (THC 11.2–24.3 ng/mL; CBD 14.4–37.0 ng/mL). The mean OF to blood ratio ranged from 0.6 to 1.2 after one and 0.6 to 1.9 after four light cannabis cigarettes. THC/CBD ratios in blood and OF were never greater than 2. Urinary 11-nor-9-carboxy-THC concentrations peaked 8 h after one and four cigarettes. Conclusions: OF was a valuable alternative to blood in monitoring consumption of light cannabis. Blood and OF THC/CBD concentration ratios, never exceeded 2, possibly providing a useful biomarker to identify light cannabis vs illegal higher THC cannabis use, where THC/CBD ratios are generally greater than 10.Keywords
This publication has 24 references indexed in Scilit:
- A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisationBMC Pharmacology and Toxicology, 2014
- Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked CannabisClinical Chemistry, 2014
- Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokersDrug Testing and Analysis, 2014
- Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis jointAnalytical and Bioanalytical Chemistry, 2013
- Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administrationAnalytical and Bioanalytical Chemistry, 2013
- Impact of enzymatic and alkaline hydrolysis on CBD concentration in urineAnalytical and Bioanalytical Chemistry, 2013
- On-Site Test for Cannabinoids in Oral FluidClinical Chemistry, 2012
- Cannabinoid Stability in Authentic Oral Fluid after Controlled Cannabis SmokingClinical Chemistry, 2012
- Pharmacokinetic Properties of 9-Tetrahydrocannabinol in Oral Fluid of Occasional and Chronic UsersJournal of Analytical Toxicology, 2010
- Conventional and Alternative Matrices for Driving Under The Influence of Cannabis: Recent Progress and Remaining ChallengesBioanalysis, 2010